Telehealth

As AI reshapes search, new awards highlight an elite group of businesses mastering online trust. Here's why your company's reputation is its biggest asset.

The telehealth giant is launching a new vertical for healthy aging, aiming to fix a market that has historically ignored women's specific biological needs.

A new Edmonton health centre embeds pharmacy services directly into patient care, aiming to fix a fragmented system and empower local pharmacists.

With a network reaching 1.2M providers, ConnectiveRx is embedding pharma messaging into clinical workflows. Is it the future of patient care or a new frontier of commercial influence?

A new federal directory aims to bring trust and safety to health apps for 68 million seniors, with standards championed early by the osteopathic community.

National Vision's annual scholarship rewards optometry students exploring AI and telemedicine, revealing a strategic investment in the future of eye care.

Eledon's tegoprubart gets Orphan Drug status, signaling a new era for liver transplant patients by potentially replacing toxic, decades-old therapies.

Promising clinical trial results for Insulet's fully closed-loop system aim to revolutionize daily management for millions with Type 2 diabetes.

Telehealth firm Direct Meds offers cheap GLP-1 drugs, but an FDA warning for "false claims" and the end of drug shortages cast a long shadow on its model.

A new report projects the telehealth market will skyrocket to over $2 trillion by 2034, signaling a seismic shift in how we receive medical care.

TelkomGroup sells its healthcare unit to focus on core digital business, as Fullerton Health expands its major presence in Indonesia's TPA market.

The National Heart Institute becomes the first hospital in Malaysia to achieve the highest global standard for digital maturity, promising a new era of patient care.

As AI reshapes medicine, one veterinary firm's 'No AI' policy is earning major awards and the loyalty of the vets it serves. Here's why.

The smart baby monitor firm posts a record $105.7M in 2025 revenue and positive adjusted EBITDA, but a significant net loss raises questions.

MDClone launches ADAMS Copilot, a GenAI tool letting clinicians analyze data with simple questions, all while keeping sensitive information safe on-site.

Sarah Sommer, a deaf digital marketing exec, joins the Oberkotter Foundation board, blending personal insight with corporate strategy to advance hearing healthcare.

Taiwanese biotech GNTbm's oral drug GNTbm-38, which turns 'cold' tumors 'hot', will begin Phase 1 trials for advanced and refractory cancers.

With a melanoma drug on track for 2027 and a deep pipeline, Immatics' 2025 net loss is part of a larger strategy to dominate PRAME cancer therapy.

With $15M from top UAE families, TruDoc is scaling its 'hospital-at-home' model, signaling a major shift in how the GCC delivers critical care.

A NY startup is using quantum computing and AI to fight aging at its source. Can Allosteric Bioscience's high-tech approach unlock a longer, healthier life?